Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia
Clinical trial NCT03027102 · COMPLETED
Trial details
- NCT number
- NCT03027102
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2024-12-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.